{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:47:23Z","timestamp":1782200843246,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"DOI":"10.1007\/s00408-026-00906-x","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:01:05Z","timestamp":1782198065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Pleural Microenvironment in Pulmonary Injury and Fibrosis: Mechanistic Insights and Links to Tissue Repair"],"prefix":"10.1007","volume":"204","author":[{"given":"Anmoy","family":"Nandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5064-7396","authenticated-orcid":false,"given":"Srijita","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"1","key":"906_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/biom16010085","volume":"16","author":"N Bakalenko","year":"2026","unstructured":"Bakalenko N, Kuznetsova E, Dergilev K, Beloglazova I, Malashicheva A (2026) Mesothelial cells in fibrosis: focus on intercellular crosstalk. Biomolecules 16(1):85. https:\/\/doi.org\/10.3390\/biom16010085","journal-title":"Biomolecules"},{"key":"906_CR2","doi-asserted-by":"publisher","unstructured":"Li Q, He X-L, Chen S-J, Niu Q, Cao T-Z, Cui X-L, Ma W-L (n.d.). Excessive collagen type VII mediates pleural fibrosis via increasing extracellular matrix stiffness. J Clin Investig, 135(24), e188822. https:\/\/doi.org\/10.1172\/JCI188822","DOI":"10.1172\/JCI188822"},{"key":"906_CR3","doi-asserted-by":"publisher","unstructured":"Qian G, Adeyanju O, Roy S, Sunil C, Jeffers A, Guo X, Tucker TA (n.d.). DOCK2 promotes pleural fibrosis by modulating mesothelial to mesenchymal transition. Am J Respir Cell Mol Biol, 66(2), 171\u2013182. https:\/\/doi.org\/10.1165\/rcmb.2021-0175OC","DOI":"10.1165\/rcmb.2021-0175OC"},{"issue":"11","key":"906_CR4","doi-asserted-by":"publisher","first-page":"118806","DOI":"10.1016\/j.bbamcr.2020.118806","volume":"1867","author":"F Liu","year":"2020","unstructured":"Liu F, Yu F, Lu Y-Z, Cheng P-P, Liang L-M, Wang M, Ye H (2020) Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis. Biochim et Biophys Acta (BBA) - Mol Cell Res 1867(11):118806. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118806","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"issue":"6","key":"906_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1165\/rcmb.2024-0549OC","volume":"73","author":"K Das","year":"2025","unstructured":"Das K, Qin W, Jeffers A, Owens S, Destarac L, Idell S, Keshava S (2025) Extracellular vesicles contribute to the pathophysiology and progression of pleural fibrosis by promoting mesothelial-to-mesenchymal transition and neoangiogenesis. Am J Respir Cell Mol Biol 73(6):938\u2013950. https:\/\/doi.org\/10.1165\/rcmb.2024-0549OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"906_CR6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1186\/s12967-024-05869-2","volume":"22","author":"Y Xia","year":"2024","unstructured":"Xia Y, Zhou F, Hui H, Dai L, Ouyang S (2024) ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target. J Translational Med 22:1114. https:\/\/doi.org\/10.1186\/s12967-024-05869-2","journal-title":"J Translational Med"},{"issue":"7","key":"906_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/life11070665","volume":"11","author":"LFS Gushiken","year":"2021","unstructured":"Gushiken LFS, Beserra FP, Bastos JK, Jackson CJ, Pellizzon CH (2021) Cutaneous wound healing: an update from physiopathology to current therapies. Life 11(7):665. https:\/\/doi.org\/10.3390\/life11070665","journal-title":"Life"},{"issue":"1","key":"906_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41421-025-00865-2","volume":"12","author":"J Agramunt","year":"2026","unstructured":"Agramunt J, Kang Y, Rinkevich Y (2026) Spatiotemporal dynamics of mammalian wound healing. Cell Discovery 12(1):4. https:\/\/doi.org\/10.1038\/s41421-025-00865-2","journal-title":"Cell Discovery"},{"key":"906_CR9","doi-asserted-by":"publisher","unstructured":"Vardakostas D, Moustogiannis A, Garoufalia Z, Karatza E, Philippou A, Kouraklis G, Mantas D (2025) Expression of tissue remodeling- and inflammation-related factors during the wound-healing process in humans. J Personalized Med 15(1). https:\/\/doi.org\/10.3390\/jpm15010014","DOI":"10.3390\/jpm15010014"},{"issue":"20","key":"906_CR10","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1042\/CS20190893","volume":"134","author":"KEC Blokland","year":"2020","unstructured":"Blokland KEC, Pouwels SD, Schuliga M, Knight DA, Burgess JK (2020) Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases. Clin Sci 134(20):2681\u20132706. https:\/\/doi.org\/10.1042\/CS20190893","journal-title":"Clin Sci"},{"issue":"5","key":"906_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/biomedicines8050101","volume":"8","author":"BZ Johnson","year":"2020","unstructured":"Johnson BZ, Stevenson AW, Pr\u00eale CM, Fear MW, Wood FM (2020) The role of IL-6 in skin fibrosis and cutaneous wound healing. Biomedicines 8(5):101. https:\/\/doi.org\/10.3390\/biomedicines8050101","journal-title":"Biomedicines"},{"issue":"1","key":"906_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1165\/rcmb.2018-0328OC","volume":"61","author":"DW Waters","year":"2019","unstructured":"Waters DW, Blokland KEC, Pathinayake PS, Wei L, Schuliga M, Jaffar J, Knight DA (2019) STAT3 regulates the onset of oxidant-induced senescence in lung fibroblasts. Am J Respir Cell Mol Biol 61(1):61\u201373. https:\/\/doi.org\/10.1165\/rcmb.2018-0328OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"906_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/cells11050817","volume":"11","author":"C-L Tsai","year":"2022","unstructured":"Tsai C-L, Changchien C-Y, Chen Y, Chang H-H, Tsai W-C, Wang Y-W, Chian C-F (2022) Accelerated wound healing and keratinocyte proliferation through PI3K\/Akt\/pS6 and VEGFR2 signaling by topical use of pleural fluid. Cells 11(5):817. https:\/\/doi.org\/10.3390\/cells11050817","journal-title":"Cells"},{"key":"906_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2021.09.001","volume":"241","author":"JE Michalski","year":"2022","unstructured":"Michalski JE, Kurche JS, Schwartz DA (2022) From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Translational Res 241:13\u201324. https:\/\/doi.org\/10.1016\/j.trsl.2021.09.001","journal-title":"Translational Res"},{"key":"906_CR15","doi-asserted-by":"publisher","first-page":"tkaf050","DOI":"10.1093\/burnst\/tkaf050","volume":"13","author":"W Bi","year":"2025","unstructured":"Bi W, Wang R, Hou S, Liu W, Zhang H, Xu Z, Jiang J (2025) Alveolar epithelial type 2 cells in acute lung injury and acute respiratory distress syndrome: spatiotemporal fate and regulation. Burns Trauma 13:tkaf050. https:\/\/doi.org\/10.1093\/burnst\/tkaf050","journal-title":"Burns Trauma"},{"key":"906_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12964-024-01925-y","volume":"22","author":"R Niayesh-Mehr","year":"2024","unstructured":"Niayesh-Mehr R, Kalantar M, Bontempi G, Montaldo C, Ebrahimi S, Allameh A, Strippoli R (2024) The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19. Cell Communication Signaling: CCS 22:542. https:\/\/doi.org\/10.1186\/s12964-024-01925-y","journal-title":"Cell Communication Signaling: CCS"},{"issue":"13","key":"906_CR17","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1016\/j.celrep.2018.03.010","volume":"22","author":"T Xie","year":"2018","unstructured":"Xie T, Wang Y, Deng N, Huang G, Taghavifar F, Geng Y, Jiang D (2018) Single-cell deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosis. Cell Rep 22(13):3625\u20133640. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.010","journal-title":"Cell Rep"},{"issue":"28","key":"906_CR18","doi-asserted-by":"publisher","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","volume":"6","author":"TS Adams","year":"2020","unstructured":"Adams TS, Schupp JC, Poli S, Ayaub EA, Neumark N, Ahangari F, Kaminski N (2020) Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv 6(28):eaba1983. https:\/\/doi.org\/10.1126\/sciadv.aba1983","journal-title":"Sci Adv"},{"key":"906_CR19","doi-asserted-by":"publisher","unstructured":"Kadri, S., Fischer, A., M\u00fcck-H\u00e4usl, M., Han, W., Kadri, A., Lin, Y., \u2026 Rinkevich,Y. (2025). A mesothelial differentiation gateway drives fibrosis. Nature Communications, 16(1), 8295. https:\/\/doi.org\/10.1038\/s41467-025-63990-2","DOI":"10.1038\/s41467-025-63990-2"},{"key":"906_CR20","doi-asserted-by":"publisher","unstructured":"Matusali G, Trionfetti F, Bordoni V, Nardacci R, Falasca L, Colombo D, Strippoli R (2021) Pleural mesothelial cells modulate the inflammatory\/profibrotic response during SARS-CoV-2 infection. Front Mol Biosci 8. https:\/\/doi.org\/10.3389\/fmolb.2021.752616","DOI":"10.3389\/fmolb.2021.752616"},{"key":"906_CR21","doi-asserted-by":"publisher","unstructured":"Wolters, P. J., Blackwell, T. S., Eickelberg, O., Loyd, J. E., Kaminski, N., Jenkins,G., Schwartz, D. A. (2018). Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? The Lancet Respiratory Medicine, 6(2), 154\u2013160. https:\/\/doi.org\/10.1016\/S2213-2600(18)30007-9","DOI":"10.1016\/S2213-2600(18)30007-9"},{"issue":"31","key":"906_CR22","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.3346\/jkms.2023.38.e242","volume":"38","author":"G Loloci","year":"2023","unstructured":"Loloci G, Kim YM, Choi W-I, Jang HJ, Park SJ, Kwon KY (2023) Properties of pleural mesothelial cells in idiopathic pulmonary fibrosis and cryptogenic organizing pneumonia. J Korean Med Sci 38(31):e242. https:\/\/doi.org\/10.3346\/jkms.2023.38.e242","journal-title":"J Korean Med Sci"},{"issue":"1","key":"906_CR23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/jcp.30500","volume":"237","author":"L-L Zhou","year":"2022","unstructured":"Zhou L-L, Cheng P-P, He X-L, Liang L-M, Wang M, Lu Y-Z, Ye H (2022) Pleural mesothelial cell migration into lung parenchyma by calpain contributes to idiopathic pulmonary fibrosis. J Cell Physiol 237(1):566\u2013579. https:\/\/doi.org\/10.1002\/jcp.30500","journal-title":"J Cell Physiol"},{"key":"906_CR24","doi-asserted-by":"publisher","unstructured":"Shen H, Zhang N, Liu Y, Yang X, He Y, Li Q, Yang Y (2022) The interaction between pulmonary fibrosis and COVID-19 and the application of related anti-fibrotic drugs. Front Pharmacol 12. https:\/\/doi.org\/10.3389\/fphar.2021.805535","DOI":"10.3389\/fphar.2021.805535"},{"issue":"12","key":"906_CR25","doi-asserted-by":"publisher","first-page":"L1265","DOI":"10.1152\/ajplung.00396.2014","volume":"308","author":"S Owens","year":"2015","unstructured":"Owens S, Jeffers A, Boren J, Tsukasaki Y, Koenig K, Ikebe M, A Tucker T (2015) Mesomesenchymal transition of pleural mesothelial cells is PI3K and NF-\u03baB dependent. Am J Physiology-Lung Cell Mol Physiol 308(12):L1265\u2013L1273. https:\/\/doi.org\/10.1152\/ajplung.00396.2014","journal-title":"Am J Physiology-Lung Cell Mol Physiol"},{"issue":"2","key":"906_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/pp-2016-0009","volume":"1","author":"K Kawanishi","year":"2016","unstructured":"Kawanishi K (2016) Diverse properties of the mesothelial cells in health and disease. Pleura Peritoneum 1(2):79\u201389. https:\/\/doi.org\/10.1515\/pp-2016-0009","journal-title":"Pleura Peritoneum"},{"key":"906_CR27","doi-asserted-by":"publisher","unstructured":"Mutsaers SE, Birnie K, Lansley S, Herrick SE, Lim C-B, Pr\u00eale CM (2015) Mesothelial cells in tissue repair and fibrosis. Frontiers in Pharmacology, 6. https:\/\/doi.org\/10.3389\/fphar.2015.00113","DOI":"10.3389\/fphar.2015.00113"},{"issue":"1","key":"906_CR28","doi-asserted-by":"publisher","first-page":"473134","DOI":"10.1155\/2014\/473134","volume":"2014","author":"M L\u00f3pez-Cabrera","year":"2014","unstructured":"L\u00f3pez-Cabrera M (2014) Mesenchymal conversion of mesothelial cells is a key event in the pathophysiology of the peritoneum during peritoneal dialysis. Adv Med 2014(1):473134. https:\/\/doi.org\/10.1155\/2014\/473134","journal-title":"Adv Med"},{"key":"906_CR29","doi-asserted-by":"publisher","unstructured":"Li W, Xie Y, Chen Z, Cao D, Wang Y (2025) Epithelial\u2013mesenchymal transition in pulmonary fibrosis: molecular mechanisms and emerging therapeutic strategies. Front Med 12. https:\/\/doi.org\/10.3389\/fmed.2025.1658001","DOI":"10.3389\/fmed.2025.1658001"},{"issue":"4","key":"906_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/path.5101","volume":"245","author":"S Namvar","year":"2018","unstructured":"Namvar S, Woolf AS, Zeef LA, Wilm T, Wilm B, Herrick SE (2018) Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses. J Pathol 245(4):491\u2013501. https:\/\/doi.org\/10.1002\/path.5101","journal-title":"J Pathol"},{"key":"906_CR31","doi-asserted-by":"publisher","unstructured":"Strippoli R, Benedicto I, Lozano MLP, Pellinen T, Sandoval P, Lopez-Cabrera M, Pozo MA (2012) del. Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells. PLOS ONE, 7(2), e31492. https:\/\/doi.org\/10.1371\/journal.pone.0031492","DOI":"10.1371\/journal.pone.0031492"},{"issue":"4\u20135","key":"906_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1242\/dmm.001321","volume":"1","author":"R Strippoli","year":"2008","unstructured":"Strippoli R, Benedicto I, P\u00e9rez Lozano ML, Cerezo A, L\u00f3pez-Cabrera M, del Pozo MA (2008) Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK\/NF-\u03baB\/Snail1 pathway. Dis Models Mech 1(4\u20135):264\u2013274. https:\/\/doi.org\/10.1242\/dmm.001321","journal-title":"Dis Models Mech"},{"key":"906_CR33","doi-asserted-by":"publisher","unstructured":"Guo, Y., Sun, L., Xiao, L., Gou, R., Fang, Y., Liang, Y., Tang, L. (2017). Aberrant Wnt\/Beta-catenin pathway activation in dialysate-induced peritoneal fibrosis. Frontiers in Pharmacology, 8. https:\/\/doi.org\/10.3389\/fphar.2017.00774","DOI":"10.3389\/fphar.2017.00774"},{"issue":"1","key":"906_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12964-023-01040-4","volume":"21","author":"W Zhao","year":"2023","unstructured":"Zhao W, Wang L, Yang J, Chen X, Guo X, Xu K, Yu G (2023) Endothelial cell-derived MMP19 promotes pulmonary fibrosis by inducing E(nd)MT and monocyte infiltration. Cell Communication Signal 21(1):56. https:\/\/doi.org\/10.1186\/s12964-023-01040-4","journal-title":"Cell Communication Signal"},{"key":"906_CR35","doi-asserted-by":"publisher","first-page":"178159","DOI":"10.1016\/j.ejphar.2025.178159","volume":"1006","author":"P Sharma","year":"2025","unstructured":"Sharma P, Kumari K, Yadav R, Verma K, Paliwal S, Paliwal S, Sharma S (2025) Molecular mechanisms and emerging therapeutics in pulmonary fibrosis: a recent update. Eur J Pharmacol 1006:178159. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178159","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"906_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12931-016-0475-8","volume":"17","author":"O Burgy","year":"2016","unstructured":"Burgy O, Bellaye P-S, Causse S, Beltramo G, Wettstein G, Boutanquoi P-M, Bonniaud P (2016) Pleural inhibition of the caspase-1\/IL-1\u03b2 pathway diminishes profibrotic lung toxicity of bleomycin. Respir Res 17(1):162. https:\/\/doi.org\/10.1186\/s12931-016-0475-8","journal-title":"Respir Res"},{"key":"906_CR37","doi-asserted-by":"publisher","unstructured":"Fischer A, Han W, Hu S, M\u00fcck-H\u00e4usl M, Wannemacher J, Kadri S, Rinkevich Y (2025) Targeting pleuro-alveolar junctions reverses lung fibrosis in mice. Nat Commun 16(173). https:\/\/doi.org\/10.1038\/s41467-024-55596-x","DOI":"10.1038\/s41467-024-55596-x"},{"key":"906_CR38","doi-asserted-by":"publisher","unstructured":"Logan, R., Jeffers, A., Qin, W., Owens, S., Chauhan, P., Komatsu, S., Tucker, T.A. (2021). TGF-\u03b2 regulation of the uPA\/uPAR axis modulates mesothelial-mesenchymal transition (MesoMT).Scientific Reports, 11(1), 21210. https:\/\/doi.org\/10.1038\/s41598-021-99520-5","DOI":"10.1038\/s41598-021-99520-5"},{"issue":"10","key":"906_CR39","doi-asserted-by":"publisher","first-page":"e146197","DOI":"10.1172\/jci.insight.146197","volume":"6","author":"L-M Liang","year":"2021","unstructured":"Liang L-M, Xiong L, Cheng P-P, Chen S-J, Feng X, Zhou Y-Y, Ma W-L (2021) Splicing factor SRSF6 mediates pleural fibrosis. JCI insight 6(10):e146197\u2013e146197. https:\/\/doi.org\/10.1172\/jci.insight.146197","journal-title":"JCI insight"},{"issue":"1","key":"906_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12931-020-1319-0","volume":"21","author":"G Epstein Shochet","year":"2020","unstructured":"Epstein Shochet G, Brook E, Bardenstein-Wald B, Shitrit D (2020) TGF-\u03b2 pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling. Respir Res 21(1):56. https:\/\/doi.org\/10.1186\/s12931-020-1319-0","journal-title":"Respir Res"},{"key":"906_CR41","doi-asserted-by":"publisher","unstructured":"Zhou, L.-L., Cheng, P.-P., He, X.-L., Liang, L.-M., Wang, M., Lu, Y.-Z., Ye, H.(2022). Pleural mesothelial cell migration into lung parenchyma by calpain contributes to idiopathic pulmonary fibrosis. Journal of Cellular Physiology, 237(1), 566\u2013579. https:\/\/doi.org\/10.1002\/jcp.30500","DOI":"10.1002\/jcp.30500"},{"issue":"1","key":"906_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/10799893.2020.1843493","volume":"42","author":"Z Sun","year":"2022","unstructured":"Sun Z, Ning Q, Li H, Hu T, Tang L, Wen Q, Shen L (2022) Transmembrane protein 88 inhibits transforming growth factor-\u03b21-induced-extracellular matrix accumulation and epithelial-mesenchymal transition program in human pleural mesothelial cells through modulating TGF-\u03b21\/Smad pathway. J Recept Signal Transduct Res 42(1):60\u201366. https:\/\/doi.org\/10.1080\/10799893.2020.1843493","journal-title":"J Recept Signal Transduct Res"},{"issue":"1","key":"906_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0115733998332692241202072249","volume":"22","author":"P Chandra","year":"2026","unstructured":"Chandra P, Faizan M, Porwal M, Sharma H, Sachan N (2026) An overview and review of growth factors in wound healing: emerging trends and innovations. Curr Diabetes Rev 22(1):1\u201327. https:\/\/doi.org\/10.2174\/0115733998332692241202072249","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"906_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-021-00166-7","volume":"41","author":"H Amano","year":"2021","unstructured":"Amano H, Matsui Y, Hatanaka K, Hosono K, Ito Y (2021) VEGFR1-tyrosine kinase signaling in pulmonary fibrosis. Inflamm Regeneration 41(1):16. https:\/\/doi.org\/10.1186\/s41232-021-00166-7","journal-title":"Inflamm Regeneration"},{"issue":"3","key":"906_CR45","doi-asserted-by":"publisher","first-page":"L359","DOI":"10.1152\/ajplung.00225.2023","volume":"327","author":"NC Olave","year":"2024","unstructured":"Olave NC, Halloran B, Ambalavanan N (2024) FGF2 is secreted in extracellular vesicles from lung cells. Am J Physiology-Lung Cell Mol Physiol 327(3):L359\u2013L370. https:\/\/doi.org\/10.1152\/ajplung.00225.2023","journal-title":"Am J Physiology-Lung Cell Mol Physiol"},{"key":"906_CR46","doi-asserted-by":"publisher","first-page":"132896","DOI":"10.1016\/j.ijbiomac.2024.132896","volume":"273Pt 1","author":"J Qi","year":"2024","unstructured":"Qi J, Wu Y, Guo Z, Zhu S, Xiong J, Hu F, Ye X (2024) Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy. Int J Biol Macromol 273Pt 1:132896. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132896","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"906_CR47","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/cells15050480","volume":"15","author":"K-L Huang","year":"2026","unstructured":"Huang K-L, Wang L-K, Tsai F-M (2026) TGF-\u03b2 signaling as a pathological continuum linking idiopathic pulmonary fibrosis and lung cancer. Cells 15(5):480. https:\/\/doi.org\/10.3390\/cells15050480","journal-title":"Cells"},{"key":"906_CR48","doi-asserted-by":"publisher","unstructured":"Bhatt J, Ghigo A, Hirsch E (2025) PI3K\/Akt in IPF: untangling fibrosis and charting therapies. Frontiers in Immunology, 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1549277","DOI":"10.3389\/fimmu.2025.1549277"},{"key":"906_CR49","doi-asserted-by":"publisher","unstructured":"Yue, B., Xiong, D., Chen, J., Yang, X., Zhao, J., Shao, J., Chen, J. (2024). SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K\/Akt\/mTOR pathway. Respiratory Research, 25(1), 362. https:\/\/doi.org\/10.1186\/s12931-024-02989-7","DOI":"10.1186\/s12931-024-02989-7"},{"issue":"1","key":"906_CR50","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.35534\/fibrosis.2023.10004","volume":"1","author":"Z Li","year":"2023","unstructured":"Li Z, Zhao H, Wang S, Yan P, Yuan H, Zhao M, Wang L (2023) Comprehensive landscape of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Fibrosis 1(1):10004. https:\/\/doi.org\/10.35534\/fibrosis.2023.10004","journal-title":"Fibrosis"},{"key":"906_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.matbio.2018.02.007","volume":"68\u201369","author":"NA Afratis","year":"2018","unstructured":"Afratis NA, Selman M, Pardo A, Sagi I (2018) Emerging insights into the role of matrix metalloproteases as therapeutic targets in fibrosis. Matrix Biol 68\u201369:167\u2013179. https:\/\/doi.org\/10.1016\/j.matbio.2018.02.007","journal-title":"Matrix Biol"},{"key":"906_CR52","doi-asserted-by":"publisher","unstructured":"Denis A, Tsiri P, Guiot J, Tzouvelekis A (2025) A new era in the treatment of progressive fibrosing interstitial lung diseases. Breathe 21(2). https:\/\/doi.org\/10.1183\/20734735.0259-2024","DOI":"10.1183\/20734735.0259-2024"},{"issue":"11","key":"906_CR53","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.21037\/jtd-2025-1254","volume":"17","author":"H Qi","year":"2025","unstructured":"Qi H, Chai X, Zhou F, Jiang Y, Bao Y (2025) A narrative review of the early diagnosis and treatment of idiopathic pulmonary fibrosis with lung cancer. J Thorac Disease 17(11):10488\u201310500. https:\/\/doi.org\/10.21037\/jtd-2025-1254","journal-title":"J Thorac Disease"},{"key":"906_CR54","doi-asserted-by":"publisher","unstructured":"Keshava S, Owens S, Qin W, Jeffers A, Kyei P, Komatsu S, Tucker TA (n.d.) The mTORC2\/SGK1\/NDRG1 signaling axis is critical for the mesomesenchymal transition of pleural mesothelial cells and the progression of pleural fibrosis. Am J Respir Cell Mol Biol 70(1):50\u201362. https:\/\/doi.org\/10.1165\/rcmb.2023-0131OC","DOI":"10.1165\/rcmb.2023-0131OC"},{"key":"906_CR55","doi-asserted-by":"publisher","unstructured":"Mutsaers SE, Krymskaya VP (n.d.). Pleural fibrosis: now that\u2019s what mTORC(ing) about. Am J Respir Cell Mol Biol, 70(1), 8\u201310. https:\/\/doi.org\/10.1165\/rcmb.2023-0327ED","DOI":"10.1165\/rcmb.2023-0327ED"},{"key":"906_CR56","doi-asserted-by":"publisher","unstructured":"Arshad M, Athar ZM, Hiba T (n.d.). Current and novel treatment modalities of idiopathic pulmonary fibrosis. Cureus, 16(3), e56140. https:\/\/doi.org\/10.7759\/cureus.56140","DOI":"10.7759\/cureus.56140"},{"issue":"2","key":"906_CR57","doi-asserted-by":"publisher","first-page":"e0318877","DOI":"10.1371\/journal.pone.0318877","volume":"20","author":"M Yang","year":"2025","unstructured":"Yang M, Tan Y, Yang T, Xu D, Chen M, Chen L (2025) Efficacy and safety of antifibrotic drugs for interstitial lung diseases other than IPF: a systematic review, meta-analysis and trial sequential analysis. PLoS ONE 20(2):e0318877. https:\/\/doi.org\/10.1371\/journal.pone.0318877","journal-title":"PLoS ONE"},{"key":"906_CR58","doi-asserted-by":"publisher","unstructured":"Jiang, M., Bu, W., Wang, X., Ruan, J., Shi, W., Yu, S., Cheng, D. (2025). Pulmonary fibrosis: from mechanisms to therapies. Journal of Translational Medicine, 23(1), 515. https:\/\/doi.org\/10.1186\/s12967-025-06514-2","DOI":"10.1186\/s12967-025-06514-2"},{"issue":"1","key":"906_CR59","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12951-024-02407-6","volume":"22","author":"M Zheng","year":"2024","unstructured":"Zheng M, Zhu W, Gao F, Zhuo Y, Zheng M, Wu G, Feng C (2024) Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects. J Nanobiotechnol 22(1):136. https:\/\/doi.org\/10.1186\/s12951-024-02407-6","journal-title":"J Nanobiotechnol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00906-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:01:07Z","timestamp":1782198067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00906-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00906-x","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human and animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"During the preparation of this work, the author(s) used Grammarly software for grammatical corrections and linguistic improvements to enhance the manuscript\u2019s clarity and readability. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the publication\u2019s content.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"39"}}